French biotechnology company Transgene, a subsidiary of Institut Mérieux, has raised a 20 million euros ($22.6 million) in equity financing.
Paris-based corporate and investment bank Natixis made the investment.
Transgene said that it will use the new funding to support its clinical and pre-clinical activities until mid-2020.
Annually, the company generates approximately $9.9 million in revenue.